Aeterna Zentaris completes $7.8M offering; High-flying startup Moderna gets former Millennium CSO as president of R&D;

@FierceBiotech: From Ex-Yahoo CEO backs genomics big data startup Bina. Article | Follow @FierceBiotech

@JohnCFierce: AstraZeneca commits $815M to partner with FibroGen on anemia drug. News | Follow @JohnCFierce

@RyanMFierce: There are no drugs approved specifically for Fragile X, a top genetic cause of autism and intellectual disability. More | Follow @RyanMFierce

@EmilyMFierce: New compound could combat castration-resistant prostate cancer. Story | Follow @EmilyMFierce

> Aeterna Zentaris ($AEZS) has completed a $7.8 million offering. Release

> The La Jolla Institute for Allergy and Immunology and Kyowa Hakko Kirin have agreed to extend their longstanding collaboration for another 6 years. Release

> Joseph Bolen has left his gig as chief scientist at Millennium Pharmaceuticals, which recently announced an R&D restructuring, and has joined the high-flying biotech startup Moderna Therapeutics as president of research and development. Release

> Bionomics Limited has made an agreement with Merck ($MRK) to discover and develop novel small molecule candidates for the treatment of chronic pain, including neuropathic pain. Release

Medical Device News

@FierceMedDev: Alere's losses triple as investor fight awaits. Story | Results | Follow @FierceMedDev

@MarkHFierce: Italy's Sorin has finally recovered from earthquake-related earnings challenges. Story | Follow @MarkHFierce

@DamianFierce: Siemens: Löscher's out; Kaeser's in; revenue's still sagging. Much more here: Report | Follow @DamianFierce

> BD joins effort to boost lab quality in China and India. Item

> Qiagen unveils $100M share repurchase plan as income improves. Report

> Trovagene hauls in $15M for diagnostics R&D. Story

Pharma News

@FiercePharma: ICYMI yesterday: Pfizer unit pleads guilty, agrees to pay $491M in off-label marketing case. Report | Follow @FiercePharma

@CarlyHFierce: Rumors swirling about an AstraZeneca Celltrion buyout, but the Korean co. says nothing is definite. Celltrion's statement | Follow @CarlyHFierce

> FDA clears Merck's Januvia, sister meds of new pancreatitis worries. Story

> Sanofi swaps leaders at animal health unit Merial. Item

> Bayer's new drugs shine, fueling 5.5% pharma growth. Article

Drug Delivery News

@MichaelGFierce: Swedish team creates 'impossible' record-breaking drug delivery material. More | Follow @MichaelGFierce

> Mallinckrodt, Depomed win priority review for oral pain med. Report

> Aussie method makes for smaller, more efficient inhaled drugs. More

> DNA-based molecular robots zero in on cancer, autoimmune diseases. Article

> Mercator snags FDA patent for blood-pressure drug delivery catheters. Item

And Finally... A researcher from Maastricht University in the Netherlands has grown the first hamburger from stem cells. The artificial burger will be served next week in London. More